MedPath

auriculotherapy and ADHD

Phase 1
Recruiting
Conditions
attention deficit hyperactivity disorder.
Attention-deficit hyperactivity disorders
Registration Number
IRCT20090527001957N9
Lead Sponsor
Research Institute for Islamic and Complementary Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

age 6-14 years
diagnosis of ADHD based on DSM- V criteria
informed consent of patients or their parents
If medication, education, occupational and psychological therapy are used, there has been no change in drug dosage or treatment or symptoms of ADHD for at least the past 2 weeks.

Exclusion Criteria

History of epilepsy
schizophrenia
neurological disorders
any psychological disorder requires medication
hyperthyroidism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of ADHD disorder. Timepoint: 1 and 3 weeks after intervention. Method of measurement: Caner's and CSI questionnaire.
Secondary Outcome Measures
NameTimeMethod
Changes of the disease severity from the viewpoint of teachers. Timepoint: 3 weeks after intervention. Method of measurement: symptom severity checklist.
© Copyright 2025. All Rights Reserved by MedPath